Oncology Learning Network® is an online resource for the latest developments in oncology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.
Through clinical insights, peer-reviewed journal articles, interactive features, research news updates, accredited continuing education (CE) programs, and professional live meetings and events, Oncology Learning Network serves as a collaborative learning and networking environment for a multidisciplinary community of oncology medical professionals.
As the digital home to the respected and well-known online and live CE programs in oncology provided by Imedex and NACCME, Oncology Learning Network allows busy oncology providers to meet all of their educational and informational needs in one place.
Oncology Learning Network is proud to partner with the following cancer organizations, with the goal of enabling both entities in the alliance to better achieve their shared mission of improving patient healthcare via the dissemination of evidence-based research to physicians and other medical practitioners in the cancer space.
The International Waldenstrom's Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-led international nonprofit organization with a simple but compelling vision and mission.
Our Vision: A world without WM.
Our Mission: Support and educate everyone affected by WM while advancing the search for a cure.
The IWMF is committed to creating a world without WM by finding a cure. Since 1999, the IWMF has invested over $18 million in WM research projects throughout the world.
Thanks to this research WM patients have better treatment options that can lead to deeper, longer lasting remissions, and fewer side effects.
LUNGevity Foundation is the nation’s leading lung cancer organization focused on improving outcomes for people with lung cancer through research, education and support for patients, survivors and caregivers, and policy initiatives. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while ensuring that health equity and access to optimal care are available for all.
LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live longer and better lives.
Comprehensive resources include a medically-vetted and patient-centric website, a toll-free HELPLine for support, the International Lung Cancer Survivorship Conference, and an easy-to-use Clinical Trial Finder, among other tools. All of these programs are to achieve our vision—a world where no one dies of lung cancer. LUNGevity Foundation is proud to be a 4-star Charity Navigator organization.
About Our Publisher
HMP Global is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care.
The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. For more information, visit hmpglobal.com.
About Our CME Providers
Imedex® is an industry leader in providing independent continuing medical education (CME) for healthcare professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our educational offerings focus on improving patient care around the world. With more than 50,000 E-learning experiences annually and more than 97,000 live meeting participants since 2001, Imedex truly educates the global healthcare community. At Imedex, education is the best medicine.®
To learn more, visit imedex.com.
NACCME (North American Center for Continuing Medical Education, LLC) is committed to developing and disseminating live, print, and web-based CME/CE activities to provide an educational forum through which healthcare practitioners may examine current medical issues, therapies, and technologies.
The content of NACCME-sponsored CME/CE activities is designed to bridge the gap between current and best healthcare practices and to improve healthcare quality by strengthening practitioner awareness of evidence-based patient care advances in a broad range of therapeutic areas.
NACCME produces CME/CE activities for physicians, pharmacists, podiatrists, nurses, physician assistants, and other allied healthcare professionals with the objective of increasing healthcare practitioner knowledge, competence, and performance, thereby improving patient outcomes.
To learn more, visit naccme.com.
© 2021, HMP. All rights reserved. Reproduction in whole or in part prohibited. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP, the editorial staff, or any member of the editorial advisory board. HMP is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. Rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate. Accuracy cannot be guaranteed. HMP disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. Content may not be reproduced in any form without written permission. Rights and Permission information is available at www.hmpglobal.com.